Formulation Of Bilayered Floating Tablets Of Atorvastatin And Niacin: Formulation And Evaluation Of Bilayered Floating Tablets Of Atorvastatin Calcium And Niacin. Este artículo no está disponible.
Idioma: inglés
Editorial: Lap Lambert Academic Publishing, 2012
- Tapa blanda
- Nuevo

Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books
Vendedor de 5 estrellas
Vendedor de IberLibro desde 6 de enero de 2003
No disponible
Tapa blanda
Condición: Nuevo
EUR 123,83
Descripción del artículo del vendedor
148 pages. 8.66x5.91x0.34 inches. In Stock.
N° de ref. del artículo __3659268593
- Título
- Formulation Of Bilayered Floating Tablets Of Atorvastatin And Niacin: Formulation And Evaluation Of Bilayered Floating Tablets Of Atorvastatin Calcium And Niacin
- Autor
- Haripriya, Puthoori; Murthy, T.E.G.K.; Kaushik, Atul; Haripriya, Puthoori; Murthy, T.E.G.K.; Kaushik, Atul
- Editorial
- Lap Lambert Academic Publishing
- Año de publicación
- 2012
- Estado
- Brand New
- Encuadernación
- Paperback
- Idioma
- inglés
- ISBN 10
- 3659268593
- ISBN 13
- 9783659268595
- Peso del artículo
- 0,27 kilogramos
In general, Cardiovascular Disease (CVD) is mainly associated with abnormal cholesterol levels (Hypercholesterolemia) in which there are increased levels of LDL and decreased levels of HDL in blood. This leads to atherosclerosis that later leads to myocardial infarction, stroke, and peripheral disease. Hence control of blood cholesterol levels is very much important to reduce the risk of CVD. In the present investigation, Atorvastatin Calcium (AT)(BCS Class II drug) an anti-hyperlipidemic agent belongs to the class Statins was formulated as an immediate release layer by using different excipients to improve the rate of dissolution. This reduces the levels of LDL and triglycerides in the blood to a major extent. On the other hand, Niacin (NA), a vitamin B3 was formulated as floating sustained release layer by using different combination of polymers to get desired drug release. Niacin in higher concentrations is used to treat hypercholesterolemia by reducing the levels of LDL, triglycerides to some extent and increases the levels of HDL to a major extent. Hence,the combination of AT and NA was found to be more beneficial than individual drugs in the treatment of hypercholesterolemia.
“Sinopsis” puede pertenecer a otra edición de este título.
Reseña del editor
In general, Cardiovascular Disease (CVD) is mainly associated with abnormal cholesterol levels (Hypercholesterolemia) in which there are increased levels of LDL and decreased levels of HDL in blood. This leads to atherosclerosis that later leads to myocardial infarction, stroke, and peripheral disease. Hence control of blood cholesterol levels is very much important to reduce the risk of CVD. In the present investigation, Atorvastatin Calcium (AT)(BCS Class II drug) an anti-hyperlipidemic agent belongs to the class Statins was formulated as an immediate release layer by using different excipients to improve the rate of dissolution. This reduces the levels of LDL and triglycerides in the blood to a major extent. On the other hand, Niacin (NA), a vitamin B3 was formulated as floating sustained release layer by using different combination of polymers to get desired drug release. Niacin in higher concentrations is used to treat hypercholesterolemia by reducing the levels of LDL, triglycerides to some extent and increases the levels of HDL to a major extent. Hence,the combination of AT and NA was found to be more beneficial than individual drugs in the treatment of hypercholesterolemia.
“Acerca de” puede pertenecer a otra edición de este título.